These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 10364559)
21. HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways. Krogh KA; Wydeven N; Wickman K; Thayer SA J Neurochem; 2014 Sep; 130(5):642-56. PubMed ID: 24666322 [TBL] [Abstract][Full Text] [Related]
22. Activation of mGluR5 attenuates NMDA-induced neurotoxicity through disruption of the NMDAR-PSD-95 complex and preservation of mitochondrial function in differentiated PC12 cells. Dai SH; Qin N; Chen T; Luo P; Zhang L; Rao W; Yang YF; Jiang XF; Fei Z Int J Mol Sci; 2014 Jun; 15(6):10892-907. PubMed ID: 24941251 [TBL] [Abstract][Full Text] [Related]
23. HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity. Vicente-Sánchez A; Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J Mol Brain; 2013 Oct; 6():42. PubMed ID: 24093505 [TBL] [Abstract][Full Text] [Related]
24. Preso regulates NMDA receptor-mediated excitotoxicity via modulating nitric oxide and calcium responses after traumatic brain injury. Luo P; Li X; Wu X; Dai S; Yang Y; Xu H; Jing D; Rao W; Xu H; Gao X; Fei Z; Lu H Cell Death Dis; 2019 Jun; 10(7):496. PubMed ID: 31235685 [TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. Brenman JE; Christopherson KS; Craven SE; McGee AW; Bredt DS J Neurosci; 1996 Dec; 16(23):7407-15. PubMed ID: 8922396 [TBL] [Abstract][Full Text] [Related]
26. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912 [TBL] [Abstract][Full Text] [Related]
27. DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. Satoh K; Yanai H; Senda T; Kohu K; Nakamura T; Okumura N; Matsumine A; Kobayashi S; Toyoshima K; Akiyama T Genes Cells; 1997 Jun; 2(6):415-24. PubMed ID: 9286858 [TBL] [Abstract][Full Text] [Related]
29. Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Zucker B; Luthi-Carter R; Kama JA; Dunah AW; Stern EA; Fox JH; Standaert DG; Young AB; Augood SJ Hum Mol Genet; 2005 Jan; 14(2):179-89. PubMed ID: 15548548 [TBL] [Abstract][Full Text] [Related]
30. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605 [TBL] [Abstract][Full Text] [Related]
31. Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. Takagi N; Logan R; Teves L; Wallace MC; Gurd JW J Neurochem; 2000 Jan; 74(1):169-78. PubMed ID: 10617118 [TBL] [Abstract][Full Text] [Related]
32. Binding of neuroligins to PSD-95. Irie M; Hata Y; Takeuchi M; Ichtchenko K; Toyoda A; Hirao K; Takai Y; Rosahl TW; Südhof TC Science; 1997 Sep; 277(5331):1511-5. PubMed ID: 9278515 [TBL] [Abstract][Full Text] [Related]
33. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. Christopherson KS; Hillier BJ; Lim WA; Bredt DS J Biol Chem; 1999 Sep; 274(39):27467-73. PubMed ID: 10488080 [TBL] [Abstract][Full Text] [Related]
34. The hDLG-associated protein DAP interacts with dynein light chain and neuronal nitric oxide synthase. Haraguchi K; Satoh K; Yanai H; Hamada F; Kawabuchi M; Akiyama T Genes Cells; 2000 Nov; 5(11):905-911. PubMed ID: 11122378 [TBL] [Abstract][Full Text] [Related]
35. Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection. Che YH; Tamatani M; Tohyama M Brain Res Mol Brain Res; 2000 Mar; 76(2):325-35. PubMed ID: 10762708 [TBL] [Abstract][Full Text] [Related]
36. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461 [TBL] [Abstract][Full Text] [Related]
37. Estradiol induces physical association of neuronal nitric oxide synthase with NMDA receptor and promotes nitric oxide formation via estrogen receptor activation in primary neuronal cultures. d'Anglemont de Tassigny X; Campagne C; Steculorum S; Prevot V J Neurochem; 2009 Apr; 109(1):214-24. PubMed ID: 19187438 [TBL] [Abstract][Full Text] [Related]
38. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Brenman JE; Chao DS; Gee SH; McGee AW; Craven SE; Santillano DR; Wu Z; Huang F; Xia H; Peters MF; Froehner SC; Bredt DS Cell; 1996 Mar; 84(5):757-67. PubMed ID: 8625413 [TBL] [Abstract][Full Text] [Related]
39. Metabotropic glutamate receptor 5, but not 1, modulates NMDA receptor-mediated activation of neuronal nitric oxide synthase. Llansola M; Felipo V Neurochem Int; 2010 Mar; 56(4):535-45. PubMed ID: 20043967 [TBL] [Abstract][Full Text] [Related]
40. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Doucet MV; O'Toole E; Connor T; Harkin A Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]